Tofacitinib in combination with glucocorticoids in the treatment of eosinophilic granulomatosis with polyangiitis: a pilot study of 11 cases

Tofacitinib, which can induce remission, prevent recurrence and taper the GC dosage, was well tolerated and may be an effective agent for the treatment of EGPA.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2025-08-14
DOI
https://doi.org/10.1093/rheumatology/keaf397
Citations
2
Primary Topic
Eosinophilic Disorders and Syndromes
Type
article
Field-Weighted Citation Impact
3.34
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tofacitinib in combination with glucocorticoids in the treatment of eosinophilic granulomatosis with polyangiitis: a pilot study of 11 cases

Rongyi Chen, Xianting Sun, Minglang Zhan, Huiyong Chen et al.
2 citations
Lara D. Veeken
Eosinophilic Disorders and Syndromes
3.34
article

Tofacitinib in combination with glucocorticoids in the treatment of eosinophilic granulomatosis with polyangiitis: a pilot study of 11 cases

Rongyi Chen, Xianting Sun, Minglang Zhan, Huiyong Chen, Yun Liu, Mengdi Li, Lindi Jiang
article en
2 citations

Abstract

Tofacitinib, which can induce remission, prevent recurrence and taper the GC dosage, was well tolerated and may be an effective agent for the treatment of EGPA.

Lara D. VeekenVol. 64(12)
Fudan University (CN), Shanghai Public Health Clinical Center (CN), Zhongshan Hospital of Xiamen University (CN), Zhongshan Hospital (CN)
Openalex Percentile: Top 7%
Eosinophilic Disorders and Syndromes
3.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.